Effects of free sugars on blood pressure and lipids: A systematic review and meta-analysis of nutritional isoenergetic intervention trials

American Journal of Clinical Nutrition

Volumn 105, Issue 1, 2017, Pages 42-56

  Fattore, Elena ^a   Botta, Francesca ^a   Agostoni, Carlo ^b   Bosetti, Cristina ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Blood pressure; Body weight; Cholesterol; Complex carbohydrates; Free sugars; Intervention trials; Meta analysis; Triacylglycerols

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBOHYDRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; SUGAR INTAKE;

ARTICLE; BLOOD PRESSURE; CALORIC INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ENERGY TRANSFER; HUMAN; INTERVENTION STUDY; META ANALYSIS; OUTCOME ASSESSMENT; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ADULT; BLOOD; DIET; DRUG EFFECTS; FEEDING BEHAVIOR; FEMALE; MALE; MIDDLE AGED; PHARMACOLOGY; SUGAR INTAKE; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD PRESSURE; CHOLESTEROL; DIET; DIETARY SUCROSE; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; HUMANS; MALE; MIDDLE AGED; TRIGLYCERIDES; YOUNG ADULT;

EID: 85008476072     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.116.139253     Document Type: Article

References (65)

1. Yudkin J. Sugar and disease. Nature 1972;239:197-9.
2. Lustig RH, Schmidt LA, Brindis CD. Public health: the toxic truth about sugar. Nature 2012;482:27-9.
3. Freeman R. Moderate evidence support a relationship between sugar intake and dental caries. Evid Based Dent 2014;15:98-9.
4. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sanchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007;86:899-906.
5. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 2001;357:505-8.
6. Te Morenga LA, Howatson AJ, Jones RM, Mann J. Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am J Clin Nutr 2014;100:65-79.
7. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537-43.
8. WHO. Sugars intake for adults and children. Geneva (Switzerland): WHO; 2015.
9. Houston M, Minich DM. Fructose-containing sugars do not raise blood pressure or uric acid at normal levels of human consumption. J Clin Hypertens (Greenwich) 2015;17:95-7.
10. Malik VS, Hu FB. Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us. JAm Coll Cardiol 2015;66:1615-24.
11. Sievenpiper JL, de Souza RJ, Mirrahimi A, Yu ME, Carleton AJ, Beyene J, Chiavaroli L, Di Buono M, Jenkins AL, Leiter LA, et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012;156:291-304.
12. Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ 2012;346:e7492.
13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
14. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
15. Israel KD, Michaelis OE 4th, Reiser S, Keeney M. Serum uric acid, inorganic phosphorus, and glutamic-oxalacetic transaminase and blood pressure in carbohydrate-sensitive adults consuming three different levels of sucrose. Ann Nutr Metab 1983;27:425-35.
16. Malerbi DA, Paiva ES, Duarte AL, Wajchenberg BL. Metabolic effects of dietary sucrose and fructose in type II diabetic subjects. Diabetes Care 1996;19:1249-56.
17. Little JA, Birchwood BL, Simmons DA, Antar MA, Kallos A, Buckley GC, Csima A. Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 1. Sucrose and starch with polyunsaturated fat. Atherosclerosis 1970;11:173-81.
18. Grande F, Anderson JT, Keys A. Sucrose and various carbohydratecontaining foods and serum lipids in man. Am J Clin Nutr 1974;27:1043-51.
19. Peterson DB, Lambert J, Gerring S, Darling P, Carter RD, Jelfs R, Mann JI. Sucrose in the diet of diabetic patients-just another carbohydrate? Diabetologia 1986;29:216-20.
20. Reiser S, Powell AS, Scholfield DJ, Panda P, Ellwood KC, Canary JJ. Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch. Am J Clin Nutr 1989;49:832-9.
21. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002;31:140-9.
22. Reiser S, Bickard MC, Hallfrisch J. Blood lipids and their distribution in lipoproteins in hyperinsulinemic subjects fed three different levels of sucrose. J Nutr 1981;111:1045-57.
23. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987;9:1-30.
24. Higgins JPT, Green SB. Cochrane handbook for systematic reviews of interventions: version 5.0.2. London: The Cochrane Collaboration; 2009.
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629-34.
27. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 2000;53:207-16.
28. Groen JJ, Balogh M, Yaron E, Cohen AM. Effect of interchanging bread and sucrose as main source of carbohydrate in a low fat diet on the serum cholesterol levels of healthy volunteer subjects. Am J Clin Nutr 1966;19:46-58.
29. Antar MA, Little JA, Lucas C, Buckley GC, Csima A. Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 3. Synergistic effect of sucrose and animal fat on serum lipids. Atherosclerosis 1970;11:191-201.
30. Birchwood BL, Little JA, Antar MA, Lucas C, Buckley GC, Csima A, Kallos A. Interrelationship between the kinds of dietary carbohydrate and fat in hyperlipoproteinemic patients. 2. Sucrose and starch with mixed saturated and polyunsaturated fats. Atherosclerosis 1970;11:183-90.
31. Mann JI, Truswell AS. Effects of isocaloric exchange of dietary sucrose and starch on fasting serum lipids, postprandial insulin secretion and alimentary lipaemia in human subjects. Br J Nutr 1972;27:395-405.
32. Reiser S, Hallfrisch J. Michaelis OE 4th, Lazar FL, Martin RE, Prather ES. Isocaloric exchange of dietary starch and sucrose in humans. I. Effects on levels of fasting blood lipids. Am J Clin Nutr 1979;32:1659-69.
33. Abraira C, Derler J. Large variations of sucrose in constant carbohydrate diets in type II diabetes. Am J Med 1988;84:193-200.
34. Cooper PL, Wahlqvist ML, Simpson RW. Sucrose versus saccharin as an added sweetener in non-insulin-dependent diabetes: short- and medium-term metabolic effects. Diabet Med 1988;5:676-80.
35. Grigoresco C, Rizkalla SW, Halfon P, Bornet F, Fontvieille AM, Bros M, Dauchy F, Tchobroutsky G, Slama G. Lack of detectable deleterious effects on metabolic control of daily fructose ingestion for 2 mo in NIDDM patients. Diabetes Care 1988;11:546-50.
36. Osei K, Bossetti B. Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein metabolism. Diabet Med 1989;6:506-11.
37. Porta M, Pigino M, Minonne A, Morisio GL. Moderate amounts of sucrose with mixed meals do not impair metabolic control in patients with type II (non-insulin dependent) diabetes. Diabetes Nutr Metab/Clin Exp 1989;2:133-7.
38. Santacroce G, Forlani G, Giangiulio S, Galuppi V, Pagani M, Vannini P. Long-term effects of eating sucrose on metabolic control of type 1 (insulin-dependent) diabetic outpatients. Acta Diabetol Lat 1990;27:365-70.
39. Bantle JP, Swanson JE, Thomas W, Laine DC. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 1992;15:1468-76.
40. Swanson JE, Laine DC, Thomas W, Bantle JP. Metabolic effects of dietary fructose in healthy subjects. Am J Clin Nutr 1992;55:851-6.
41. Bantle JP, Swanson JE, Thomas W, Laine DC. Metabolic effects of dietary sucrose in type II diabetic subjects. Diabetes Care 1993;16:1301-5.
42. Koivisto VA, Yki-Jarvinen H. Fructose and insulin sensitivity in patients with type 2 diabetes. J Intern Med 1993;233:145-53.
43. Piatti PM, Pontiroli AE, Saibene A, Santambrogio G, Paroni R, Magni F, Galli-Kienle M, Mistrali S, Monti LD, Pozza G. Insulin sensitivity and lipid levels in obese subjects after slimming diets with different complex and simple carbohydrate content. Int J Obes Relat Metab Disord 1993;17:375-81.
44. Surwit RS, Feinglos MN, McCaskill CC, Clay SL, Babyak MA, Brownlow BS, Plaisted CS, Lin PH. Metabolic and behavioral effects of a high-sucrose diet during weight loss. Am J Clin Nutr 1997;65:908-15.
45. Black RN, Spence M, McMahon RO, Cuskelly GJ, Ennis CN, McCance DR, Young IS, Bell PM, Hunter SJ. Effect of eucaloric highand low-sucrose diets with identical macronutrient profile on insulin resistance and vascular risk: a randomized controlled trial. Diabetes 2006;55:3566-72.
46. Johnston RD, Stephenson MC, Crossland H, Cordon SM, Palcidi E, Cox EF, Taylor MA, Aithal GP, Macdonald IA. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology 2013;145:1016-25.e2.
47. Lewis AS, McCourt HJ, Ennis CN, Bell PM, Courtney CH, McKinley MC, Young IS, Hunter SJ. Comparison of 5% versus 15% sucrose intakes as part of a eucaloric diet in overweight and obese subjects: effects on insulin sensitivity, glucose metabolism, vascular compliance, body composition and lipid profile. A randomised controlled trial. Metabolism 2013;62:694-702.
48. Vaisman N, Niv E, Izkhakov Y. Catalytic amounts of fructose may improve glucose tolerance in subjects with uncontrolled non-insulindependent diabetes. Clin Nutr 2006;25:617-21.
49. Johnson LK, Holven KB, Nordstrand N, Mellembakken JR, Tanbo T, Hjelmesaeth J. Fructose content of low calorie diets: effect on cardiometabolic risk factors in obese women with polycystic ovarian syndrome: a randomized controlled trial. Endocr Connect 2015;4:144-54.
50. Mann JI, Truswell AS, Manning EB. Effects on serum lipids of reducing dietary sucrose or starch for 22 weeks in normal men. S Afr Med J 1972;46:827-34.
51. Silbernagel G, MacHann J, Unmuth S, Schick F, Stefan N, Häring HU, Fritsche A. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr 2011;106:79-86.
52. Osei K, Falko J, Bossetti BM, Holland GC. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med 1987;83:249-55.
53. Jayalath VH, Sievenpiper JL, de Souza RJ, Ha V, Mirrahimi A, Santaren ID, Blanco Mejia S, Di Buono M, Jenkins AL, Leiter LA, et al. Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts. J Am Coll Nutr 2014;33:328-39.
54. Ha V, Sievenpiper JL, de Souza RJ, Chiavaroli L, Wang DD, Cozma AI, Mirrahimi A, Yu ME, Carleton AJ, Dibuono M, et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 2012;59:787-95.
55. Visvanathan R, Chen R, Garcia M, Horowitz M, Chapman I. The effects of drinks made from simple sugars on blood pressure in healthy older people. Br J Nutr 2005;93:575-9.
56. Brown CM, Dulloo AG, Montani JP. Sugary drinks in the pathogenesis of obesity and cardiovascular diseases. Int J Obes (Lond) 2008;32(Suppl 6):S28-34.
57. Brown CM, Dulloo AG, Yepuri G, Montani JP. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 2008;294:R730-7.
58. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987;10:512-6.
59. Dolan LC, Potter SM, Burdock GA. Evidence-based review on the effect of normal dietary consumption of fructose on blood lipids and body weight of overweight and obese individuals. Crit Rev Food Sci Nutr 2010;50:889-918.
60. Dolan LC, Potter SM, Burdock GA. Evidence-based review on the effect of normal dietary consumption of fructose on development of hyperlipidemia and obesity in healthy, normal weight individuals. Crit Rev Food Sci Nutr 2010;50:53-84.
61. Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010;33:2477-83.
62. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-33.
63. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-33.
64. Ramsden CE, Zamora D, Majchrzak-Hong S, Faurot KR, Broste SK, Frantz RP, Davis JM, Ringel A, Suchindran CM, Hibbeln JR. Reevaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ 2016;353:i1246.
65. Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, Cuchel M, DerOhannessian S, Kontush A, Surendran P, Saleheen D, et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 2016;351:1166-71.